Use of Data Monitoring Committees in Clinical Trials, Guidance for Industry （draft guidance）——interpret the development and practice of Data Monitoring Committee from the updated FDA guidelines
ZHENG Yu, DANG Hai-xia, LIU Jun, WANG Zhong, YU Ya-nan
Chinese Journal of New Drugs . 2026, (5): 470 -475 .  DOI: 10.20251/j.cnki.1003-3734.2026.05.005

Total:
Copyright © Chinese Journal of New Drugs, All Rights Reserved.
Tel: 010-52722697 | 010-52723707
　 Powered by Beijing Magtech Co., Ltd.